Shah M - Search Results

1

A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.

Tse AN, Klimstra DS, Gonen M, Shah M, Sheikh T, Sikorski R, Carvajal R, Mui J, Tipian C, O'Reilly E, Chung K, Maki R, Lefkowitz R, Brown K, Manova-Todorova K, Wu N, Egorin MJ, Kelsen D, Schwartz GK. Tse AN, et al. Among authors: shah m. Clin Cancer Res. 2008 Oct 15;14(20):6704-11. doi: 10.1158/1078-0432.CCR-08-1006. Clin Cancer Res. 2008. PMID: 18927314 Free PMC article. Clinical Trial.

2

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

Shah MA, Schwartz GK. Shah MA, et al. Clin Cancer Res. 2001 Aug;7(8):2168-81. Clin Cancer Res. 2001. PMID: 11489790 Review.

3

The relevance of drug sequence in combination chemotherapy.

Shah MA, Schwartz GK. Shah MA, et al. Drug Resist Updat. 2000 Dec;3(6):335-356. doi: 10.1054/drup.2000.0165. Drug Resist Updat. 2000. PMID: 11498402

4

Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts.

Motwani M, Jung C, Sirotnak FM, She Y, Shah MA, Gonen M, Schwartz GK. Motwani M, et al. Among authors: shah ma. Clin Cancer Res. 2001 Dec;7(12):4209-19. Clin Cancer Res. 2001. PMID: 11751522

5

[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].

Shah MA, Kelsen DP. Shah MA, et al. Chirurg. 2002 Apr;73(4):325-30. doi: 10.1007/s00104-002-0459-8. Chirurg. 2002. PMID: 12063916 German.

6

Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.

Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP. Brenner B, et al. Among authors: shah ma. Br J Cancer. 2004 May 4;90(9):1720-6. doi: 10.1038/sj.bjc.6601758. Br J Cancer. 2004. PMID: 15150595 Free PMC article.

7

Combined modality therapy of esophageal cancer: changes in the standard of care?

Shah MA, Kelsen DP. Shah MA, et al. Ann Surg Oncol. 2004 Jul;11(7):641-3. doi: 10.1245/ASO.2004.04.907. Epub 2004 Jun 14. Ann Surg Oncol. 2004. PMID: 15197008 No abstract available.

8

Treatment of metastatic esophagus and gastric cancer.

Shah MA, Schwartz GK. Shah MA, et al. Semin Oncol. 2004 Aug;31(4):574-87. doi: 10.1053/j.seminoncol.2004.04.013. Semin Oncol. 2004. PMID: 15297948 Review.

9

Cyclin-dependent kinases as targets for cancer therapy.

Shah MA, Schwartz GK. Shah MA, et al. Cancer Chemother Biol Response Modif. 2003;21:145-70. doi: 10.1016/s0921-4410(03)21007-3. Cancer Chemother Biol Response Modif. 2003. PMID: 15338744 Review.

10

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB. Chung KY, et al. Among authors: shah m. J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,872 results

Search Page

Filters